GRAMD4 and hepatocellular carcinoma: Furthermore, we also confirmed that GRAMD4 was an independent predictive factor for the DFS of HCC patients in the Tongji cohort (HR, 0.496; 95% CI:, 0.282–0.873; p  = 0.015, Supporting information Figure S2C and D).